GE HealthCare Technologies Inc. GEHC
Stock research in plain language · As of Oct 25, 2026 · updated once a week, after the trading week closes

Daily candles, 50 and 200-day averages and volume · updated every trading day · click to open the live chart
What the company does
GE HealthCare Technologies Inc. is a large-cap company in the Healthcare sector (Medical Devices), with a market value of $32.3B, based in the USA.
It employs about 54,000 people and has been listed since Jan 04, 2023.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
Cheap or expensive? relatively cheap
Its price-to-earnings (P/E) is 16.4 versus 36.9 for the median of the Healthcare sector in our universe (25 companies) — relatively cheap.
Revenue is growing 6% versus the same quarter last year.
The average analyst price target is 82.70, 16% above the current price (their view, not ours).
The stock sits at 41% of its one-year range (0% = the low, 100% = the high).
The risks
- • More cash leaves than comes in (negative free cash flow).
- • Quarterly report in 3 days (2026-10-28) — a day the stock can move a lot.
Strengths
- ✅ Profitable — 11 of every 100 dollars of revenue stays as profit.
- ✅ Most analysts rate it buy (16 vs 0).
- ✅ Pays a dividend (0.2% a year).
What changed this week
Over the past week the stock rose 2.8% (for comparison: S&P 500 -0.4%, sector ETF XLV +1.4%).
This week's news
- 1 cash-producing stock worth investigating and 2 we turn down finance.yahoo.com · 2026-10-23
What the article says
1 cash-producing stock worth investigating and 2 we turn down While strong cash flow is a key indicator of stability, it doesn't always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning. Luckily for you, we built StockStory to… source ↗
- Global Breast Cancer Screening and Diagnostics Market, 2026-2036 | AI Imaging and Wider Screening Push Breast-Cancer Diagnostics Toward $12 Billion finance.yahoo.com · 2026-10-23
What the article says
Company Logo The global breast cancer screening and diagnostics market is projected to roughly double from $5.9 billion in 2026 to $12.15 billion by 2036, a new Research and Markets report finds, as GE HealthCare, Hologic and Siemens Healthineers roll out new imaging and AI tools despite high equipment costs. Dublin,… source ↗
- GE HealthCare Technologies (GEHC) vs. DHR and MDT: Can a $23.9B Backlog and AI Innovation Drive a Healthcare Re-Rating? finance.yahoo.com · 2026-10-22
What the article says
Is GEHC a good stock to buy? We came across a bullish thesis on GE HealthCare Technologies Inc. on Astute Optics - US's Substack. The thesis was published on September 13th, when the stock was trading at $64.25, and GEHC gained 9.30% since then. The gain appears to reflect improving sentiment toward healthcare stocks… source ↗
- GEHC Expands Theranostics Imaging With 5 Global Collaborations finance.yahoo.com · 2026-10-22
What the article says
GE HealthCare GEHC recently announced five new global clinical collaborations to evaluate its next-generation StarGuide GX digital SPECT/CT system, aimed at advancing quantitative imaging, dynamic imaging and emerging theranostics applications. The program involves leading healthcare institutions across the United… source ↗
- Body Composition Analyzers Market Size and Global Forecast to 2031 | Obesity and Preventive Care Fuel Demand for Body Composition Analyzers finance.yahoo.com · 2026-10-21
What the article says
Company Logo The global body composition analyzers market is projected to grow from $0.99 billion in 2026 to $1.39 billion by 2031, a new report finds, with bioimpedance devices growing fastest; GE HealthCare, Omron, InBody and Tanita are among the companies profiled. Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Body… source ↗
- The Conference Board Honors Six CEOs at 2026 Distinguished Leadership Awards Celebration finance.yahoo.com · 2026-10-20
What the article says
NEW YORK, Oct. 20, 2026 /PRNewswire/ -- Tomorrow evening, The CEO Center of The Conference Board will honor six business leaders and their companies for outstanding leadership in challenging times. The annual Distinguished Leadership Awards Celebration will take place in New York City. For more than 30 years, the… source ↗
What changed since last week
No material change: same valuation verdict, same risk flags, price moved less than 3%.
A description of facts from the filings and the market — not investment advice or a recommendation. "Cheap" and "expensive" are always relative to the comparison group. Educational information only — not investment advice. Not a registered investment adviser or broker-dealer.